These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 17878098)

  • 1. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
    Genevay M; Gengler C; Guillou L
    Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of genetic testing in soft tissue sarcoma.
    Antonescu CR
    Histopathology; 2006 Jan; 48(1):13-21. PubMed ID: 16359533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Soft tissue sarcomas: update on molecular data].
    Bui Nguyen Binh M; Collin F; Coindre JM
    Cancer Radiother; 2006; 10(1-2):15-21. PubMed ID: 16442827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group.
    Mertens F; Strömberg U; Mandahl N; Dal Cin P; De Wever I; Fletcher CD; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van Den Berghe H; Vanni R; Willén H
    Cancer Res; 2002 Jul; 62(14):3980-4. PubMed ID: 12124330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pathology of soft tissue sarcomas].
    Schmidt D
    Radiologe; 1992 Dec; 32(12):579-83. PubMed ID: 1492148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Specific chromosome aberrations in human soft-tissue tumors and their diagnostic significance].
    Mrózek K; Gibas Z; Limon J
    Pol Tyg Lek; 1995 Sep; 50(36-39):85-9. PubMed ID: 8650044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of cytogenetics to the management of poorly differentiated sarcomas.
    Bridge JA
    Ultrastruct Pathol; 2008; 32(2):63-71. PubMed ID: 18446669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET.
    Riggi N; Cironi L; Suvà ML; Stamenkovic I
    J Pathol; 2007 Sep; 213(1):4-20. PubMed ID: 17691072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment].
    Yamaguchi U; Hasegawa T
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1340-5. PubMed ID: 15446553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
    Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
    Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is fine-needle aspiration biopsy a practical alternative to open biopsy for the primary diagnosis of sarcoma? Experience with 140 patients.
    Kilpatrick SE; Cappellari JO; Bos GD; Gold SH; Ward WG
    Am J Clin Pathol; 2001 Jan; 115(1):59-68. PubMed ID: 11190808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Targeted therapy of sarcomas].
    Cassier PA; Dufresne A; El Sayadi H; Pissaloux D; Alberti L; Decouvelaere AV; Ranchere D; Ray-Coquard I; Blay JY
    Bull Cancer; 2008 Oct; 95(10):963-74. PubMed ID: 19004727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
    Fadare O
    Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphology and molecular biology of malignant soft tissue sarcomas].
    Katenkamp D
    Praxis (Bern 1994); 1998 Aug; 87(34):1043-9. PubMed ID: 9757787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in the genomics of soft tissue sarcomas.
    Conley AP; Trent J; Zhang W
    Curr Opin Oncol; 2008 Jul; 20(4):395-9. PubMed ID: 18525334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical relevance of molecular genetics in soft tissue sarcomas.
    Ordóñez JL; Osuna D; García-Domínguez DJ; Amaral AT; Otero-Motta AP; Mackintosh C; Sevillano MV; Barbado MV; Hernández T; de Alava E
    Adv Anat Pathol; 2010 May; 17(3):162-81. PubMed ID: 20418671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of prognostic indicators for sarcomas of the soft parts and the viscerae.
    Rudolph P; Bonichon F; Gloeckner K; Collin F; Chassevent A; Schmidt D; Coindre JM; Parwaresch R; Klöppel G
    Verh Dtsch Ges Pathol; 1998; 82():246-52. PubMed ID: 10095442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome changes in soft tissue sarcomas.
    Becher R; Wake N; Gibas Z; Ochi H; Sandberg AA
    J Natl Cancer Inst; 1984 Apr; 72(4):823-31. PubMed ID: 6323809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What is the value of recent molecular biology knowledge for surgical oncologic therapy of soft tissue sarcoma?].
    Willeke F
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():393-8. PubMed ID: 9931648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.